Preliminary study of the plasma and cerebrospinal fluid concentrations of IL-6 and IL-10 in patients with chronic pain receiving intrathecal opioid infusions by chronically implanted pump for pain management

Pain Medicine

Volumn 11, Issue 4, 2010, Pages 550-561

  Zin, Che S ^a   Nissen, Lisa M ^a   O'Callaghan, James P ^c   Moore, Brendan J ^a,c   Smith, Maree T ^a,b  

^a School of Pharmacy and   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GREENSLOPES PRIVATE HOSPITAL   (Australia)

Author keywords

Cerebrospinal Fluid; Cytokine; Interleukin 10; Interleukin 6; Intrathecal Opioid

Indexed keywords

AMITRIPTYLINE; BUPIVACAINE; FENTANYL; GABAPENTIN; HYDROMORPHONE; INTERLEUKIN 10; INTERLEUKIN 6; LOCAL ANESTHETIC AGENT; MORPHINE; PREGABALIN; ROPIVACAINE; VALPROIC ACID;

ADULT; AGED; ARTICLE; CHRONIC PAIN; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; INFUSION PUMP; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PAIN ASSESSMENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; TREATMENT DURATION;

EID: 77952791628     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00821.x     Document Type: Article

References (33)

1. Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci 2005, 6:521-32.
2. Watkins LR, Hutchinson MR, Ledeboer A. Glia as the " bad guys": Implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun 2007, 21:131-46.
3. Watkins LR, Hutchinson MR, Milligan ED, Maier SF. " Listening" and " talking" to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Rev 2007, 56:148-69.
4. McMahon SB, Cafferty WBJ, Marchand F. Immune and glial cell factors as pain mediators and modulators. Exp Neurol 2005, 192:444-62.
5. Watkins LR, Maier SF. Glia: A novel drug discovery target for clinical pain. Nat Rev Drug Discov 2003, 2:973-85.
6. Wieseler-Frank J, Maier SF, Watkins LR. Glial activation and pathological pain. Neurochem Int 2004, 45:389-95.
7. Cunha FQ, Ferreira SH. Peripheral hyperalgesic cytokines. Adv Exp Med Biol 2003, 521:22-39.
8. Deleo JA, Colburn RW, Nichols M. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J Interferon Cytokine Res 1996, 16:695-700.
9. Qui Z, Sweeney DD, Netzeband JG, Gruol DL. Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci 1998, 18:10445-56.
10. Inomata Y, Hirata A, Yonemura N, Koga T, Kido N, Tanihara H. Neuroprotective effects of interleukin-6 on NMDA-induced rat retinal damage. Biochem Biophys Res Commun 2003, 302:226-32.
11. Callizot N, Andriambeloson E, Glass J. Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity. Cancer Chemother Pharmacol 2008, 62:995-1007.
12. Schoeniger-Skinner DK, Ledeboer A, Frank MG. Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120. Brain Behav Immun 2007, 21:660-7.
13. Jordan M, Otterness IG, Ng R. Neutralization of endogenous IL-6 suppresses induction of IL-1 receptor antagonist. J Immunol 1995, 154:4081-90.
14. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators. Immunol Today 1997, 18:428-32.
15. Oka T, Wakugawa Y, Hosoi M, Oka K, Hori T. Intracerebroventricular injection of tumor necrosis factor-alpha induces thermal hyperalgesia in rats. Neuroimmunomodulation 1996, 3:135-40.
16. Reeve AJ, Patel S, Fox A, Walker K, Urban L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 2000, 4:247-57.
17. Woolf CJ, Allchorne A, SafiehGarabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: The contribution of tumour necrosis factor alpha. Br J Pharmacol 1997, 121:417-24.
18. Milligan ED, Langer SJ, Sloane EM. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci 2005, 21:2136-48.
19. Sommer C. Cytokines and neuropathic pain. Neuropathic Pain: Pathophysiology and Treatment 2001, 37-62. Hansson PTFields HLHill RGMarchettini P. In, eds., Seattle, IASP Press
20. Milligan ED, Sloane EM, Langer SJ. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 2006, 126:294-308.
21. Sweitzer S, Martin D, DeLeo JA. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 2001, 103:529-39.
22. Watkins LR, Hutchinson MR, Johnston IN, Maier SF. Glia: Novel counter-regulators of opioid analgesia. Trends Neurosci 2005, 28:661-9.
23. Johnston IN, Milligan ED, Wieseler-Frank J. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 2004, 24:7353-65.
24. Raghavendra V, Rutkowski MD, DeLeo JA. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 2002, 22:9980-9.
25. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000, 117(4):1162-72.
26. Strle K, Zhou JH, Shen WH. Interleukin-10 in the brain. Crit Rev Immunol 2001, 21(5):427-49.
27. Backonja MM, Coe CL, Muller DA, Schell K. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J Neuroimmunol 2008, 195:157-63.
28. Ellison VJ, Mocatta TJ, Winterbourn CC, Darlow BA, Volpe JJ, Inder TE. The relationship of CSF and plasma cytokine levels to cerebral white matter injury in the premature newborn. Pediatr Res 2005, 57:282-6.
29. Schafers M, Sommer C. Anticytokine therapy in neuropathic pain management. Expert Rev Neurother 2007, 7:1613-27.
30. Scholz J, Woolf CJ. The neuropathic pain triad: Neurons, immune cells and glia. Nature Neurosci 2007, 10:1361-8.
31. Reyes-Gibby CC, El Osta B, Spitz MR. The influence of tumor necrosis factor-a-308 G/A and IL-6-174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiol Biomarkers Prev 2008, 17:3262-7.
32. Bianchi M, Maggi R, Pimpinelli F Rubino T. Presence of a reduced opioid response in interleukin-6 knockout mice. Eur J Neurosci 1999, 83:419-25.
33. Song P, Zhao ZQ. The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001, 39:281-6.